Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects
Public ClinicalTrials.gov record NCT00845429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immunogenicity of Two Dosages of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine Administered in Healthy Adult Subjects Aged 18 to 49 Years
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objective: To describe the immune response to a single administration of 2 formulations of the investigational cell-based influenza vaccines in healthy adult subjects. Secondary Objective: To describe the safety following a single administration of 2 formulations of the investigational cell-based influenza vaccines in healthy adult subjects.
Study identification
- NCT ID
- NCT00845429
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 729 participants
Conditions and interventions
Conditions
Interventions
- Influenza virus vaccine - cell-based (2007-2008 Formulation) Biological
- Influenza virus vaccine (2007-2008 Formulation) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 49 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- Aug 2008 (Actual)
- Completion
- Nov 2008 (Actual)
- Last update posted
- Dec 19, 2012
2007 – 2008
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hoover | Alabama | 35216 | — |
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Milford | Connecticut | 06460 | — |
| Not listed | Pinellas Park | Florida | 33781 | — |
| Not listed | Chicago | Illinois | 60610 | — |
| Not listed | Wichita | Kansas | 67207 | — |
| Not listed | Kansas City | Missouri | 64114 | — |
| Not listed | Springfield | Missouri | 65802 | — |
| Not listed | Cary | North Carolina | 27518 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Cincinnati | Ohio | 45249 | — |
| Not listed | Bensalem | Pennsylvania | 19020 | — |
| Not listed | Warwick | Rhode Island | 02886 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00845429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2012 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00845429 live on ClinicalTrials.gov.